1.5 Year Survival Rate and Prognostic Factors of Renal Cell Carcinoma According to the TNM Stages Defined in 1997.
Eun Ho SON ; Chang Kyu LEE ; Hyun Yul RHEW
Korean Journal of Urology 2000;41(1):15-22
No abstract available.
Carcinoma, Renal Cell*
;
Survival Rate*
2.Scanning electron microscopic findings of the rat femoral head vascular architecture using a corrosion casting.
Chang Soo KANG ; Woo Yul LEE ; Kwan Kyu PARK
The Journal of the Korean Orthopaedic Association 1993;28(5):1866-1873
No abstract available.
Animals
;
Corrosion Casting*
;
Corrosion*
;
Head*
;
Rats*
3.The role of the Computed Tomography in Head and Neck Cancer: Comparison of CT Staging with Clinical Staging in Oral Cavity, Oropharynx and Larynx Cancer
Kee Hyun CHANG ; Yul LEE ; Man Chung HAN
Journal of the Korean Radiological Society 1985;21(1):40-48
Thirty-six patients (24 with oral cavity or oropharynx cancers and 12 larynx cancers) were prospectively examined with computed tomography (CT) to determine its value in staging the primary tumor and to compare with the clinical staging. The CT staging agreed with the clinical staging in 50% (12/24) of the oral cavity or oropharynx cancers and in 67% (8/12) of the larynx cancers. The CT upgraded the clinical staging in 29% (7/24) of the oral cavity or oropharynx tumors and in 33% (4/12) of the larynx cancers, whereas the CT downgraded the clinical staging in 21 % (5/24) of the oral cavity or oropharynx cancers. There is no downgrade on CT in larynx cancer. The post-surgical confirmation was not made in most of the cases. The possible causes of disagreement between the CT and the clinical staging, and the diagnostic value of the CT in evaluation of the primary tumor in oral cavity, oropharynx and larynx were discussed.
Head and Neck Neoplasms
;
Head
;
Humans
;
Laryngeal Neoplasms
;
Larynx
;
Mouth
;
Oropharyngeal Neoplasms
;
Oropharynx
;
Prospective Studies
4.Preliminary Study on von Hippel-Lindau Gene Mutations in Sporadic Clear Cell Renal Carcinomas.
Chang Kyu LEE ; Hyun Yul RHEW ; Hee Kyung CHANG ; Song Jae LEE
Korean Journal of Urology 2000;41(7):812-818
No abstract available.
Carcinoma, Renal Cell*
5.An experimental study on MRI signal intensity vs concentration of water-soluble contrast media.
Ghi Jai LEE ; Kee Hyun CHANG ; Moon Hee HAN ; Chang Yul HAN ; Man Chung HAN
Journal of the Korean Radiological Society 1991;27(3):310-316
No abstract available.
Contrast Media*
;
Magnetic Resonance Imaging*
6.The Diagnostic Value of Computere Tomography in Head and Neck Cancer.
Yul LEE ; Chang Hae SUH ; Kee Hyun CHANG
Journal of the Korean Society for Therapeutic Radiology 1984;2(1):139-148
No abstract available.
Head and Neck Neoplasms*
;
Head*
7.T lymphocyte subsets, B lymphocyte and NK cell activity in cervical intraspithelial neoplasia and cervical cancer patients.
Seung Chull LEE ; Jong Ho CHANG ; Kwan Soo KIM ; Heong Yul LEE
Korean Journal of Obstetrics and Gynecology 1993;36(7):2667-2673
No abstract available.
Humans
;
Killer Cells, Natural*
;
Lymphocytes*
;
T-Lymphocyte Subsets*
;
Uterine Cervical Neoplasms*
8.A clinical analysis of fistula-in-ano.
Sang Yul CHO ; Tae Young JUNG ; Chang Woo LEE ; Sang Hyun KIM
Journal of the Korean Surgical Society 1991;41(4):520-524
No abstract available.
9.Fanconi Anemia.
Sang Il LEE ; Young Yul KOH ; Jung Gi SUH ; Hyo Seop AHN ; Chang Yee HONG
Journal of the Korean Pediatric Society 1981;24(2):153-163
No abstract available.
Fanconi Anemia*
10.T cell subsets of peripheral blood in patients with bladder cancer.
Chang Kyu LEE ; Jong Chul KIM ; Hyun Yul RHEW
Korean Journal of Urology 1993;34(3):426-430
Recently, to find a change of cellular immunologic function, the development of monoclonal anti-body for surface antigen of T cell subsets is used as an important method of quantitative and functional measure in T cell subsets. We evaluated the T cell subsets in the peripheral blood of 145 normal control group and 106 bladder cancer group which was diagnosed by tissue pathology during the period from June 1986 to June 1992. The results of this study showed that CD3 of T cell subsets was significantly decreased in bladder cancer group as compared with normal control group(p<0.05) and significantly decreased in T1 and T1 groups of bladder cancer groups(p<0.05). But CD4/CD8 ratio was not decreased in bladder cancer group as compared with normal control group.
Antigens, Surface
;
Humans
;
Immunity, Cellular
;
Pathology
;
T-Lymphocyte Subsets*
;
Urinary Bladder Neoplasms*
;
Urinary Bladder*